These reports demonstrate that high numbers of CD3+, CD8+, or CD45RO+ T cells in tumour tissue are significantly correlated with lower frequencies of lymph node metastasis or disease recurrence, or longer patient survival. This evidence concerns the gene CD8A and neoplasm.